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Abstract  
Background: It’s decelerated that childhood obesity is a global epidemic since 21st 
century. General obesity has doubled since 1980 and comes with a distinct increase 
of mobility and mortality. Obesity also correlate with future consequences in form of 
different diseases such as metabolic syndrome, cancer and increased risk of chronic 
diseases and not to mention the increased cost for the society. The condition is 
undoubtable multifactored and the precise mechanism behind are still incomplete. 
Previous studies have suggested an indirect pathogenicity of methanogens, 
favouring other microbes’ growth and in that way correlate in obesity. In this work the 
aim was to further investigate this possible correlation by analysing levels of 
methanogens in obsese and lean children. The analysis was made directly in faecal 
samples and after incubation of feaces in a nutrient solution. The hypothesis was that 
a small but important difference in methanogenic levels between lean and obese 
children exist but might be too low to be statistically proven and that an incubation 
allowing growth of the methanogens would ease the detection and result in a 
stronger signal. 
 
Methods: The participants in the study was assigned to lean- or obese group 
depending on S-BMI, a total of 29 participants. Faecal samples and anthropometrical 
data were collected from the two groups. Levels of methanogens in feaces, non-
incubated and after 48h anaerobic incubation in a nutrient solution, was determined 
by quantitative PCR targeting the 16S-ribosomal RNA. Methanogen groups included 
in the analysis was Methanobacteriales (MBT), Methanosaetaceae (MST), 
Methanosarcinaceae (MSC) and Methanomicrobiales (MMB).  
 
Results and conclusion: The results showed a general low abundance of 
methanogen quantification in the different groups, except for the MBT group. The 
abundance of  MSC, MMB and MST were at the point for detection, making the 
results quite uncertain. MBT however, were well detected and specific for its selected 
primers. Furthermore, a correlation between BMI and MBT was significantly lower in 
the obese group compared to the lean group in the non-incubated samples, and an 
even greater significance was seen in the incubated samples. The incubation aspect 
is unique for this study and according to hypothesis highlighted a significant 
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correlation between levels of MBT and BMI. Further studies are needed to 
understand the importance of methanogens and their activity on effects of diet and 
obesity in childhood. 
 
Keywords: Childhood obesity, gut microbiota, methanogens, Methanobrevibacter (MBT) 
 
Populärvetenskaplig sammanfattning  
Mag-tarmkanalens mående speglar ofta människans hälsa i stort. Koppling mellan 
tarmflorans komposition och övervikt har i djur- och humana studier visat sig ha en 
korrelation och forskning pågår just nu avsevärt för att försöka kartlägga 
sjukdomssamband, maghälsa och tarmflorans inflytande i människans liv. Övervikt är 
något som ökar runt om i värden och har lett till ett folkhälsoproblem. I denna studie 
undersöks specifikt övervikt i ung ålder då detta leder till en markant ökad risk för 
övervikt även i vuxen ålder. Detta indirekt ökar risken till följdsjukdomar som till 
exempel kroniska tillstånd och metabola syndromet (övervikt och diabetes). Det 
metalbolasyndromet har bland annat visat sig öka risken för hjärtinfarkt fem gånger 
jämfört med normalindividen, varför övervikt i unga år är av stor vikt att bekämpa. 
Övervikt och vem som drabbas har flera orsaker och kartläggningen till dessa 
mekanismer är fortfarande inte helt klart.  Som tidigare nämnt fokuseras mycket 
forskning inom området på kopplingen mellan övervikt och tarmfloras 
sammansättning och aktivitet, där bland annat metanogener, olika bakterier samt 
kortkedjade fettsyror (mikrobiella nedbrytningsprodukter) visat sig ha en korrelation 
till övervikt. Metanogener producerar metan ifrån väte som frigörs tillsammans med 
kortkedjade fettsyrorna när olika bakterier fermenterar (bryter ner) kolhydrater. I två 
tidigare associerade studier gjorda på samma deltagare fann man en ökad nivå av 
propionat i överviktiga jämfört med normalviktiga barn men ingen tydlig koppling till 
sammansättningen av olika bakterier. I denna studie kompletteras dessa studier men 
en analys av metanogener, för att undersöka dessa mikroorganismers potentiella 
korrelation till övervikt hos barn. Insamling av material i from av avföringsprover och 
kroppsmätningar ifrån deltagarna samlades in. Där det olika metanogena grupperna 
sedan mättes i avföringsproverna. En av de metanogena grupperna, som fanns i 
högst nivå, undersöktes också efter det att mikroorganismerna i avföringsproverna 
fått växa till sig i en i näringslösning, detta för att få ett mått på individuell potentiell 
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tillväxt av metanogener och för att tydligare kunna identifiera eventuella kopplingar 
mellan dessa, nivåer och fettsyror och övervikt. Resultaten visade en signifikant 
skillnad i nivåerna av en specifik metanogen grupp, Methanobacteriales (MBT) hos 
överviktiga jämfört med normalviktiga barn, men en lägre nivå in de förra. En positiv 
korrelation fanns också mellan nivåerna av fettsyror och samma metanogen. Denna 
studie var unik då den studerade tarmflorans sammansättning efter tillväxt i 
näringslösning, som visade sig ge en större åtskillnad mellan den överviktiga och 
normalviktiga gruppen. Dock krävs det mer forskning för att slutgiltigt bevisa att 
halten av metanogener är en riskfaktor för övervikt.  
 
Nyckelord: Övervikt hos barn, tarmflora, metanogener, Methanobrevibacter (MBT) 
 
 
Background 
Since the beginning of 21st century the world health organization (WHO) declared an 
increase in overweight among children as a global epidemic, especially in economy 
developed countries around the world (Spruijt-Metz. 2011). An excess of body fat can 
be a general definition of obesity, but there is no clear threshold for the amount of fat 
that is normal and abnormal (Cole et al., 2000). Furthermore, to measure bodyfat in 
general are complicated and expensive why an adjustment for height are taking 
place and obesity are then defined as an excess of weight after this adjustment. The 
body mass index (BMI) is an equation of bodyweight (kg) divided to the persons 
height (m)2. Definition of overweight and obesity in adults are 25 kg/m2  and 30 kg/m2  
respectively. However, in children due to a natural continuing changing in body mass 
and growing, a standard BMI (S-BMI) are being used and are corelated to the 
children’s age and gender for evaluation the child’s status. BMI over 25 kg/m2 has 
been linked to heath distractions, such as for example hypertension and increased 
cholesterol (Fredamn et al., 1999) as well as typ ll diabetes (Pinhas-Hamiel,. 1996), 
non-alcoholic fatty liver, the metabolic syndrome, polycystic ovarian syndrome and 
increased risk for lifelong chronic diseases (Cruz et al,. 2005), not to forget 
colorectal-, breast- and kidney cancer (Calle et al,. 2004), just to mention a few. The 
reason to increased obesity worldwide are many but two key factors seems to be the 
most important, which is easy excess to food with high energy density and decreased 
activity in daily life (Prentice et al., 2003). This leads to an increase in energy storage 
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as fat tissue, due to increased energy in- and decreased energy out, leading to an 
energy unbalance and fat gain. Studies have also shown a distinct risk for being 
overweight as an adult if overweight as a youth, which conclude a lifespan treat 
already in a young age (Singh et al., 2008). Obesity in childhood and adolescent also 
comes with a cost for the society (Finkelstein et al., 2009). Compare to a normal 
weighted person the cost for an obese individual is a 42% higher medical spending 
per capita (US), which corresponds to the total health cost for problematic alcohol 
drinking or smoking (Strum., 2002). This in conclusion shows a very high public 
heath priority for preventing, treating and understanding obesity in children and 
adolescent (Koplan., et al 2005).  
The gut microbiota                                                                               
Humans are no exceptions when it comes to surrounding microbes and its 
association in all multicellular organism (Neish., 2008). The microbiota is coexisting 
microorganisms such as bacteria’s, viruses, unicellular eukaryotes and archaea living 
in harmony with their host. The intestinal tract consists of up to 100 trillion microbes 
with an environment packed full of nutrients (Gill et al., 2006). The most dominant 
microbes are members belonging to the bacteria Phyla Firmicutes and Bacteroidetes 
(>99%) and also the methanogenic Archaea Methanobrevibacter smithii. The 
different bacteria are mostly anaerobes, but aerobes reside as well in the gut 
(Sekirov et al,. 2010). Interestingly, different amounts of microbiome are scattered 
throughout the gut with a lower abundance proximally in the initial gastrointestinal 
(GI) tract and an increase in volume and diversity of microbes in the distal colon. The 
gut microbiome helps to regulate the immune system, modulate the gut motility, 
acquisition in nutrients and vitamins, protection of pathogen invasion and aid in 
digestion (Bull and Plummer, 2014). It simply works in symbiosis with the host in 
healthy subjects. However, it´s evident that alterations of the gut flora for some 
diseases is associated with a change of the function or composition of the gut 
microbiome. Since we are born with a sterile GI tract the microbes that populate the 
GI tract are colonised rapidly after birth (Bawagan,. 2019). It has previously been 
suggested that the gut microbiome has been stabilised and adult-like around year 1-
3, but indication has shown a continuing development until adult (Hollister et al., 
2015). A pilot study showed a significant separation of the microbial composition in 
faecal samples of the pre-adolescents children compare to the samples of adults, 
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supporting the previous hypothesises above (Paliy et al,. 2009). Dependent on infant 
delivery, the initial colonisation of the gut also differs (Dominguez-Bello et al,. 2010). 
The colonization will resemble the virginal canal or bacterial milieu related to the skin 
dependent on traditional vaginal delivery or caesarean delivery respectively. 
Moreover, breast or formula fed infants also depend the establishment of the 
microbiota (Harmsen et al,. 2000). The microbiota gradually changes in number with 
an increase of obligate anaerobic species and number reduction of facultative 
anaerobes and aerobes in early childhood (Hopkins et al,. 2005). If no disturbance 
factors such as antibiotics, environmental factors or diseases comes in place, a 
steady state reaches during the teens and smaller changes throughout the adulthood 
occurs minimally if no disturbance factors as above transpire (Hollister et al,. 2015). 
However, differences in the gut microbiome between individuals in the same age has 
been shown and a core gut microbiome are thus difficult to define of the bacteria on a 
species level (Lozupone et al,. 2012).  
Studies in mice have shown a positive correlation between the ratio of Firmicutes to 
Bacteroidetes and BMI (Ruth et al,. 2006). In another study the same correlation  
with humans (Turnbaugh et al., 2006). Obese subjects had the same ratio as obese 
mice’s, which decreased after fat reduction, and a hypothesis of a correlation 
between these phylum and obesity was grounded. However, studies have, after the 
formulation of this hypothesis, showed contradictory results and relevance of these 
bacteria and its correlation to obesity was questioned (Schwiertz., 2010). 
Correlations between obesity and different bacterial groups such as Bifidobacterium 
was shown, with a lower abundance Bifidobacterium towards obesity. Also, 
methanogens and Short-Chain Fatty Acids (SCFA) respectively in correlation to 
obesity was found. More specific, the level of methanogens and SCFA was shown to 
be significantly lower respectively higher in obese subjects.   
Methanogens         
Methanogens of the digestive system belong to the phylum Eukaryota in the archaea 
domain. It’s a single-cell organism of an ancient field and they are strict anaerobes 
(Ghavami et al,. 2018). Methanogens are found in in the gut of humans and animals 
but also for example in fresh water, sewage and soil (Nkamga et al., 2017). In the 
human body methanogens have been found in the oral cavity, intestinal mucosa, 
virginal mucosa and on the skin (Nkamga et al., 2017). In 1982 only two 
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methanogens were cultured in the human gastrointestinal tract and three years later 
six methanogens were isolated from specimens of human stool (Nkamga et al., 
2017). The six groups found in the human gut microbiota are: 
Methanobrevibacter smithii, Methanosphaera stadtmanae, Methanomassiliicoccus 
luminyensis, Methanosarcina species (sp), Methanosphaera sp and 
Methanobrevibacter oralis (Enzmann et al., 2018). Methanogens enhance food 
fermentation via saccharolytic bacteria thorough reduction of produced hydrogen to 
methane (van de Pol., 2017).  In addition to hydrogen, methanogens can also use 
other substrates, such as acetate, methylamine and formate (Enzmann et al., 2018). 
Methanogens are divided in different groups according to substrate use, such as 
hydrogenotroph that can use hydrogen and methylotroph using for example 
methylamines, methanol and acetate. Of the methanogen detected in the gut most 
are hydrogenotrophic. However, Methanomassiliicoccus, using methylamine and 
Methanosarcina, using in addition to hydrogen also acetate and methanol, are 
methylotrophs. Acetate utilizing methanogens, such as Methanosarcina are also 
called acetoclastic methanogens. 
 
Methanogens – positive and negative health factors  
The upcoming science has seen associations in different levels of methanogens and 
its correlation to a positive and negative input of the host after found in the large 
intestine and mouth. Associations between methanogens, levels and composition, 
and various conditions, such as colon cancer, diverticulosis, (de Marcario et al., 
2008) infectious diseases and chronic constipation (Nkamga et al., 2017) have been 
seen. Methanogens also seems to trigger specific B and T cells in the innate and 
adaptive immune activation in humans and animals. On a subcellular level  increase 
in proinflammatory cytokines and modulation of antimicrobial peptides have been 
shown to be released (Sereme et al., 2019). The healthy conditions mentioned above 
were all associated with a general high quantity  of methanogens (non-identified 
specific group in the GI tract. However, studies have also shown a positive effect, 
with methanogens contributing with reducing the levels of trimethylamine(used as 
substrate) which results in an indirect decrease of the production levels of 
trimethylamine oxide (TMAO), a pro-atherogenic factor. In other words, methanogen 
can decrease the risk of atherosclerosis (obstruction of the coronary arteries) and 
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help in prevention of cardiovascular diseases, then called archeabiotics (Brugere et 
al,. 2014). 
 
Obesity and methanogens  
Furthermore, correlation of obesity and intestinal methanogens was recently 
proposed as well (Nkamga et al., 2017). Its specific pathogenicity seems to be 
indirect, where the actual pathogenesis comes from favouring the growth of other (de 
Marcario et al., 2008). An establishment of weight gain, caloric harvest and metabolic 
diseases such as obesity has been associated with an increased level of total 
methanogens (Nkamga et al., 2017). In comparison, other studies have shown the 
opposite where anorectic subjects had a higher methanogen level compare to normal 
weighted subjects (Armougom., 2009). Furthermore, two other studies based on 
body mass index showed a lower methanogenic abundance in obese subjects 
(Zhang., 2009), (Million., 2013).  
 
Factors influencing levels of methanogens 
Important to note is that methanogens are present at different abundance and is 
aged dependent (Peled et al., 1985). Peled and co-workers had a study with almost 
400 infants, children and adolescents to investigate the percentage of methane 
production by measuring the level in breath. Infants and up to 3 years had no 
production of methane while 3-4, 7-14- and 14-18-years group had 6,4%,  14,3-
18,2%  and 39,4-45,9% methane production in the breath , respectively. Adults 
showed with 49% methane in the breath. Furthermore, it’s not only age that have am 
important impact on methanogen production. This study showed an increase of 
methane associated with diary intake, which shows that different external factors 
such as food intake can change the gut microbiota and its composition (van de Pol., 
2017).  
 
Hypothesis  
Methanogens produce methane from hydrogen produced during fermentation of 
carbohydrates and a correlation between methanogenic abundance in 
gastrointestinal tract and obesity have been suggested in humans. In this study 
methanogenic abundance was analysed in faecal samples from lean and obese 
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children before and after incubation of the samples in a nutrient solution. We 
hypothesized that the obese group should have comparably lower abundance and 
that the incubation would enhance the difference between the two investigated 
groups. 
 
Method 
Study setup  
In this study methanogenic abundance was analysed with qPCR as described below 
using DNA samples extracted in a previous master study (Ingman., 2019). In this 
previous study the bacterial community was analysed by illumina sequencing.  The 
results from the analyses of methanogenic abundance in this study was correlated 
against various patient parameters and SCFA, data collected in another previous 
master work (Ehn., 2017). A short description of the previous studies is included 
below to or clearance and better understanding of the set-up of this study. For more 
information and details of the previous projects, se references.  
 
Design of the study – criteria of study participants – ethical review 
This study is included in Uppsala Longitudinal Study of Childhood Obesity 
(ULSCO)/Beta JUDO-study. It’s a non-randomised study and non-blinded for the 
researches regarding the collection of data and samples from the participants, where 
the groups are based on S-BMI.  We have two groups with a total of 29 participants, 
one control group based on S-BMI <25 (15 participants) and a patient group based 
on S-BMI >30 (14 participants). Age <18 years and S-BMI under- or over 25 and 30 
respectively are the inclusion criteria. Medicine with gut microbiota impact (based 
from a physician), metformin, antibiotics or acarbose treatment three months prior to 
the study or gastrointestinal diseases are the exclusion criteria. Information (written 
and verbally) was given to all participants and commitment was given on consent to 
participate in the same way, including caretakers. Information about their rights to 
withdraw on any occasion was also given. Blood pressure, body composition, faeces 
and fasted blood samples was taken and was ethical approval by Swedish Ethical 
Review Authority registration number 2012/318/ and 2012/318.  
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The RedCap database and Uppsala Academic hospital schedule at the obesity unit 
was used to find candidates with help from a M.D and M.L. A request and information 
were given by phone and further written information about the current study and the 
general ULSCO study was sent with an acceptance envelope. Following was also 
included in the envelope; Faecal sample collecting tubes with instruction, a topical 
lidocaine-based anaesthetic, nitrile gloves and a general health form for whom was 
interested to participate in the study.  
Faecal samples 
The faecal samples were instructed to be taken not more than 2 days before the 
appointment at Uppsala Children’s Hospital and refrigerated until collected. The 
faecal samples were refrigerated until transported to Swedish University of 
Agriculture Science laboratory for analysis, not later than 3 days after the collection 
at the hospital.   
 
Anthropometry  
A wall-mounted stadiometer (Busse, Ulmer stadiometer) was used to record the 
height of all participants. Two measurement’s without shoes was made and a 
calculation of the average in 0,1cm was recorded. The digital scale (SECA 704) was 
used to record the body weight in the same manner as for height. Weight of clothing, 
0,5 kg, was subtracted from the weight that was recorded within 0,1 kg. After these 
two measurements S-BMI (age adjusted BMI) could be calculated. Calculations and 
records of bodyweight, body fat mas and fat percentage were measured via a 
bioelectrical impedance analysis (MC980-MA).  
 
Laboratory analysis performed in previous studies of importance 
for present work  
Levels of SCFA and composition of the bacteria community structure were measured 
in the previous mentioned master projects, using high performance liquid 
chromatography analysis (HPLC) and Illiumina sequencing, respectively (Ehn,. 2017; 
Ingman,. 2019). The faecal samples used for the analyses started with non-incubated 
samples and further investigation after 48 hours of incubation in a sucrose containing 
nutrient medium. Triplicate DNA extractions were made direct from feaces for all the 
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samples, called 0-hurs samples or non-incubated samples. The bacterial culturing 
process for the incubating samples was made through the method described from 
Westerholm et al,. 2010. In brief, the feaces was mixed with a nutrient medium and 
0,4 ml of sucrose, under anaerobic circumstances. The samples were then placed in 
a room of 37 degrees Celsius for 48 hours.   
Real-Time Quantitative PCR  
Different methanogen groups Methanobacteriales (MBT), Methanosaetaceae (MST), 
Methanosarcinaceae (MSC), Methanomicrobiales (MMB) and total methanogens was 
analysed by qPCR using group specific primers targeting the 16S rRNA gene (table 
1). To quantify the methanogens in the samples, a standard curve was used as a 
baseline. Purified PCR product with a pGEM ligated into the vectors with noted 
copies was used. A dilution of the purified PCR product was made, creating a 
standard curve with copies of 108, 107, 106 , 105 continuously down to 101 copies per 
μl. Further, a dilution test of the faecal DNA samples was initially made to optimise 
PCR reaction. The DNA samples used in the PCR analysis were diluted 10, 100, 200 
and 500 times. The samples diluted 200 times showed the best performance and  
further applied for all samples in the analysis.  
The individual samples were mixed as below: 
 10 µl master mix (iQ SYBR green supermix Bio-Rad, Hercules, CA, USA) 
 1 µl forward primer (10pmol/µL) 
 1 µl reverse primer (10pmol/µL) 
 5 µl nuclease-free water 
 3 µl DNA (see table 1. below for specific details)  
A well fitted 96- well plate prepared with reaction solution, primers and template DNA 
was then placed into the Real-Time System (BIO-RAD CFX96TM) for reaction and 
calculation. 
The different methanogens had different sequences why the PCR machine settings 
were slightly different. The  same number of cycles were used, but the primer melting 
temperature (Tm) was different (Table 1). The methanogenic abundance was 
measured by qPCR using the CFX96 C1000 Thermal Cycler from Bio-Rad (Hercules, 
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CA, USA). A melt curve was performed in the end of the program to detect any non-
specific amplicons or primer dimers by a temperature rise from 55-95°C (ΔT=0.1°C s-
1). For statistically data a T-test and/or ANOVA test was performed.  
 
Table 1. List of primers used to quantify methanogenic groups of archea 
 
Microbal Group Target species Primer  Sequence 
(5’3’) 
Tm 
 (°C) 
 
 
Methanomicrobiales MMB-f1 
MMB-r1 
ATC GRT ACG GGT TGT GGG   
CAC CTA ACG CRC ATH GTT TAC 
66 
 
 Methanobacteriales  MBT-f 2 
MBT-r2 
CGW AGG GAA GCT GTT AAG T 
TAC CGT CGT CCA CTC CTT 
58 
 
Methanogens Methanosaetaceae  Mst-f1         
Mst-r1 
TAA TCC TYG ARG GAC CAC CA 
CCT ACG GCA CCR ACM AC  61 
 
 Methanosarcinaceae Msc-f1       
Msc-r1 
GAA ACC GYG ATA AGG GGA 
TAG CGA RCA TCG TTT ACG  60 
 
 Total methanogens Met630f3 
Met803r3 
 
GGA TTA GAT ACC CSG GTA GT 
GTT GAR TCC AAT TAA ACC GCA 
 
63 
1Source: Westerholm., et al, (2011) 
2Source: Westerholm., et al (2012) 
3Source: Hook., et al (2009) 
 
 
 
Results 
Participants  
A total of 29 subjects was involved in the study, aged between 8-17 years. Control- 
and patient group was based on S-BMI non-randomised. Control group had 15 
subjects and S-BMI <25. Patient group had 14 subjects and S-BMI >30. Every 
subject in the patient group was patients at the obesity clinic at Uppsala Academic 
Children’s hospital. 3 subjects in both groups for data of 48 hours incubation samples 
of MBT was not included in 16s-rRNA-analysis, leaving the control group with 12 
subjects and the patient group with 11 subjects (note; only for the incubation test). 
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Table 2. Anthropometric data and characteristics of participants of direct feaces. 
 Controls  Patients  
 Mean ± SD  Mean ± SD  
N=  15 14 
Sex (Female : Male)  7:8 6:8  
Age (years)  12:47 ± 2,77 13.27 ± 2,79 
S-BMI (kg/m2)  18.29 ± 2.82 32.43 ± 5.02 
Body fat percentage (%)  21.19 ± 6.30 42.01 ± 5.23 
Body fat mass (kg)  11.55 ± 6.50 37.98 ± 12.14 
 
 
 
Methanogens  
Quantification of the different methanogenic groups showed in general very low 
abundance. The abundance of  MSC, MMB and MST were at the point for detection, 
making the results quite uncertain. MBT and total methanogens were however 
detected above 107 copies per µl. Consider the level of total methanogens a trend for 
a lower level in the obese group was shown, but the difference is not significant (T-
test p=0,703). However, the levels of MBT in feaces showed a significant correlation 
with BMI, with a decreased level of MBT in the obese group compare to the lean 
group for the 0h samples (ANOVA p=0,01) and 48 hours samples (ANOVA p=0,0). 
Two statistics analysis was made to increase the strength of this specific result, 
ANOVA and T-test, which both showed a significant correlation between BMI and 
MBT, for both incubated and non-incubated samples.  
In summary, MSC, MMB and MST could not be used for statistical analyses due to 
the low and uncertain values. However, MBT was well detected and significantly 
correlated to BMI, with a significantly lower amount of MBT in the obese group (table 
3). For the non-incubated samples, the level of total methanogens as well showed a 
correlation to BMI, with lower levels in the feaces for the obese group. 
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Table 3. List of results from methanogens in non-incubated feaces, copies per µl. 
 Patientgrupp (mean ± SD) 
(copies/µl) 
Controll (mean ± SD) 
(copies/µl) 
N= 14 15 
Tot-met 1,46^8 ± 5,80^7 1,80^8 ± 1,14^8 
MBT  4,40^7 ± 1,88^7 3,97^7 ± 2,40^7 
MST  <10^4 <10^4  
MMB  8,99^4 ± 7,18^4 1,92^5 ± 6,60^4 
MSC 4,25^5 ± 1,37^5  2,12^5 ± 9,66^4 
 
Bacteria and SCFA  
To reveal connection between specific groups of bacteria and levels of SCFA, data 
from previously done Illumina sequencing and HPLC  analyses were further 
investigated in this study. Results from Illumina sequencing are given in relative 
abundance and data for some bacteria, before and after incubation, were  included in 
a  correlation analysis. The results showed no significant correlation between the 
bacterial groups Firmicutes, Bacteroidetes or Bifidobacterium to BMI, body fat, MBT, 
SCFA and age. However, a trend of a correlation between Firmicutes and 
Bacteroidetes, when one was trending high the other one was trending low. In the 
samples from the 48 hours incubation a significant correlation was obtained between 
SCFA and MBT (p=0,01) with a higher level of SCFA in the obese group and a lower 
rate in the lean group. A correlation between BMI and SCFA was also seen (p=0,1).   
Table 4. List of anthropometric data and results of each individual of non-incubated feaces samples.  
Age 
(years) 
S-BMI 
(kg/m2) 
Body fat 
percentage (%) 
MBT 0h  Bifidobacterium 
0h (%) 
Firmicutes 
0h (%)  
Bacteroidetes 
0h (%) 
Total SCFA 
0h (g/l) 
13 18,9 15,8 2,21^7 ± 9,87^6 12,0 19,5 67,2 <0,2  
9 19,5 16,8 7,35^7 ± 5,61^6 11,0 20,4 62,2 <0,2 
12 19,8 15 2,31^8 ± 2,03^8 3,3 46,2 44,3 <0,2  
8 20,9 21,3 1,37^7 ± 7,52^6 3,7  38,5 51,4 <0,2  
11 21,2 16,9 2,16^7 ± 2,15^7 1,4  17,4 79,3 <0,2  
17 21,2 24,3 1,67^7 ± 1,36^7 0,0  48,8 46,2 <0,2  
14 21.4 13,4 4,55^7 ± 7,38^6 1,0 46,2 44,3 <0,2  
14 22 27,7 2,51^7 ± 2,18^7 22,0  56,8 14,5 <0,2  
16 22,2 27,9 1,30^8 ± 2,42^6 0,0    31,5 65,8 <0,2  
17  
 
 
 
 
11 22,7 25,3 1,34^7 ± 4,68^6 15,0  38,5 45,5 <0,2  
16 23,6 28,8 2,14^7 ± 7,26^6 28,0  37,7 30,0 <0,2  
14 24,6 33,6 3,38 ^7 ± 8,42^6  2,3    16,8 79,9 <0,2  
13 31,3 37,2 5,09^7 ± 3,61^7 2,5    53,5 41,2 <0,2  
17 32,2 36,1 6,82^7 ± 5,48^6 2,1  65,9 31,7 <0,2  
11 32,9 43,1 6,69^7 ± 0,00 11,0  81,6 4,5 <0,2  
16 33,5 33,2 4,74^7 ± 3,99^6 3,2    63,9 31,1 <0,2  
11 35,3 49,9 3,51^7 ± 1,88^6 7,5    39,5 52,8 <0,2  
13 37 36,1 3,66^7 ± 4,42^7 19,2  34,7 45,9 <0,2  
9 38,2 42,9 3,07^7 ± 1,48^7 1,0    28,7 69,4 <0,2  
17 38,5 45,7 1,22^7 ± 0,00 0,0    37,8 60,7 <0,2  
16 39,2 44,7 6,02^7 ± 2,66^7 4,6    53 42,5 <0,2  
10 39,7 47,6 3,63^7 ± 2,00^7 1,4    15,6 82,7 <0,2  
17 42 46,7 7,08^6 ± 2,38^6 38,0  26,6 32,1 <0,2  
 
 
Table 5. List of  anthropometric data and results of each individual of 48 hours incubated faecal samples 
Age 
(years) 
S-BMI 
(kg/m2) 
Body fat 
percentage (%) 
MBT 48h  Bifidobacterium 
48h (%) 
Firmicutes 
48h (%)  
Bacteroidetes  
48h (%) 
Tot SCFA  
48h (g/l) 
13 18,9 15,8 4,20^5 ± 1,53^5 88,5 6,8 3,6 2,19 
9 19,5 16,8 6,11^5 ± 2,81^5 80,1 6,2 11,2 2,25 
12 19,8 15 6,29^5 ± 8,80^4 60,0 29 7,2 2,41 
8 20,9 21,3 5,83^5 ± 2,39^5  44,5 17,8 5,1 2,45 
11 21,2 16,9 2,95^5 ± 1,84^5 25,4 60,5 9,2 1,85 
17 21,2 24,3 2,93^5 ± 2,25^5 78,2 1,4 14,7 1,79 
14 21.4 13,4 2,19^5 ± 1,03^5 72,0 9,5 16,1 1,66 
14 22 27,7 3,18^5 ± 5,48^4 86,0 4,0 2,4 2,36 
16 22,2 27,9 4,15^5 ± 1,32^5 51,0 41,1 7,1 2,78 
11 22,7 25,3 1,94^5 ± 1,18^5 33,0 35,6 30,3 2,22 
16 23,6 28,8 3,09^5 ± 1,95^5 44,5 51,3 3,1 2,08 
14 24,6 33,6 2,01^5 ± 1,09^5 21,4 5,2 66 1,50 
13 31,3 37,2 1,43^5 ± 2,27^4 59,0 24,4 8,7 2,55 
17 32,2 36,1 1,27^5 ± 7,38^5 13,1 13,5 11,2 1,87 
11 32,9 43,1 1,62^5 ± 2,73^4 79,0 6,4 1,6 1,73 
16 33,5 33,2 1,33^5 ± 1,62^4 14,0 75,7 6,9 1,86 
11 35,3 49,9 2,79^5 ± 1,68^5 50,0 46,8 3,6 2,29 
13 37 36,1 1,23^5 ± 8,20^4 68,0 22,4 8,9 2,52 
9 38,2 42,9 3,57^5 ± 2,08^5 78,0 17,3 4,7 3,35 
17 38,5 45,7 1,03^5 ± 1,41^4 3,5  35,4 60,4 1,89 
16 39,2 44,7 1,50^5 ± 3,47^4 17,0 76,3 6,0 2,17 
10 39,7 47,6 2,25^5 ± 1,57^5 44,0 50,8 5,3 3,04 
17 42 46,7 3,68^5 ± 2,79^5 86,0 10 3,1 2,62 
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Discussion  
Gut microbiota  
Obesity is undoubtedly multifactored and several studies have shown changes in the 
gut microbiota as one important factor correlating with obesity, where a precise 
mechanism of metabolic function remains unknown. Overweight and obesity is a 
global epidemic where an unbalance between energy intake, consumption and 
storage is seen to be dysregulated in these areas. The potential role of the gut 
microbiota is a growing interest in the pathophysiology of obesity and wellbeing to 
health and has been widely acknowledged recent years. Possible findings in the gut 
microbiota and its correlation to obesity has in several studies been shown and a 
new significant focus is now in process (Ley,. Et al 2006; Turnbaugh., et al 2006). 
Mouse models have shown fascinating correlations between weight gain and gut 
microbiota, for example, a relationship between different bacteria abundance with 
potential increased energy harvest (Turnbaugh et al., 2006). Gut microbiota has been 
correlated to possible contribution of weight gain through implicated mechanism, 
including increased lipogenic substrate thorough increased SCFA absorption and 
production (Samuel et al., 2008), fatty acid oxidation suppressed via AMP-activation 
protein kinase in the liver (Bäckhed et al,. 2004), insulin resistance due to increased 
lipopolysaccharide production (Cani et al., 2007) and also incretin hormone 
regulation (Cani et al., 2009) just to name a few. Recently a correlation between 
methanogens and obesity was found in animals and humans. Previous studies have 
mainly have measured methanogenic levels in feaces, without incubations, which  
makes  this study unique as in in addition also included measurements of 
methanogens after incubation. 
Methanogens 
This study showed a significant correlation between obesity and MBT which has 
been shown before, as described below. However, this study is the first to 
demonstrate the correlation between MBT and BMI after incubation, which showed 
an even greater significant potential. The significant correlation between MBT and 
BMI showed a lower level of this methanogenic group in the obese group. In the non-
incubated samples, a similar significant correlation was found but the significance 
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increased after the 48 hours incubation. The lower abundance of MBT in obese 
subjects in this study is in line with the results of Schwiertz and co-worker’s, finding 
the same correlation in humans (Schwiertz et al., 2010). In contrast, Mbakwa and co-
workers presented a study showing a correlation between higher abundance of MBT 
in feaces and obesity (Mbakwa et al., 2015). But it’s important to note that differences 
in diet, gut genome, exercise and other factors could alter the original gut microbiota 
and impact on the outcomes (Schwiertz et al., 2010).  
 
Further studies have shown a correlation between increased body fat percentage 
and high BMI with increased methane and hydrogen levels in breath (Basseri et al., 
2012). The hypothesis introduced in their study was that higher levels of methane 
presented as an inhibited effect on the motility of the small intestine and indirectly 
decreased the transition of the food, which contributed to increased nutrient 
availability. A consequence of this colonization of methanogens and indirect 
enhanced nutrient availability showed an increased correlation to weight gain. 
However, breath methane measurements require 108 per gram of dry weight in cell 
number to be detected (Weaver et al., 1986) which could make Basseri and co-
workers result uncertain due to exclusion of potential important differences below that 
level of the individuals. Another interesting factor about methanogens is that they are 
located in the same region as the L cells, which produce glucagon-like peptide (GLP-
1), which in turn regulates glucose and appetite regulation (Laverdure et al,. 2018). 
The study showed that methane stimulated the GLP-1 secretion and in turn 
increased the intracellular cAMP content. A simultaneous significant correlation 
between GLP-1 secretion and methanogen abundance was shown in a mice model 
feed on a high-fat diet (Laverdure et al,. 2018).  
 
The different outcome in the studies mentioned above support that a more detailed 
mechanism has to be revealed for methanogenic colonisation, but new prevention 
targets might be provided for diseases associated with the methanogenic presence.  
 
Conclusively, the methanogenic groups MMB, MSC and MST were too low for good 
detection as the measured levels were close to detection limits.  MST seemed initially 
to be  highly abundant but after additional data analysis only unspecific products 
were found, most likely because MST levels were below detection levels. Important 
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to note and a weakening point for the investigation of methanogens is that there is an 
uncertain degree of growth of methanogens in the human body. The abundance has 
also been shown to be correlated to the age of the host, where younger children 
have lower levels than adults. The origin of the uncertain degree of growth of 
methanogens is unknown but a hypothesis that different colonic floras could play a 
roll, with further investigation needed to confirm the hypothesis (Peled et al., 1985).  
Further, a study concluded that on a western diet all their participants had presence 
of methanogens, with levels differing up to 10 logs between subjects (Miller T.L., and 
Wlin M.J., 1986). In light of this, a potential difference between the individuals and 
correlation to BMI in all methanogenic groups could be present, but with a lower 
detectable threshold then in the present analysis 
 
SCFA  
In the 48 hours incubation, the analysis showed higher SCFA values, with a 
significant higher value in the obese group. This indicates an increased ability of 
fermentation of carbohydrates to SCFA in the gut microbiota of obese children 
compared to the lean children. This result was in line with previous studies showing 
similar results of a higher level of SCFA associated with obese subjects (Schewiertz 
et al., 2010; de la Cuesta-Zuluaga et al., 2018). SCFA are considered as a precursor 
for cholesterol, for liponeogenesis, protein synthesis and for gluconeogenesis which 
indirect indicate weight gain (Schwiertz et al., 2010).   
Furthermore, a significantly higher abundance of SCFA correlated with levels of MBT 
in our study. More specific, a correlation was found for higher levels of SCFA and 
lower levels of MBT in the obese group, which are in line with previous studies 
(Clifton et al., 2011; Abell et al., 2006). The physiology behind this phenomenon are 
likely increased food fermentation and SCFA production, mainly acetate, butyrate 
and propionate through reduction of hydrogen and production of methane mainly 
(Topping D.L., and Clifton P.M 2001). Acetate, butyrate and propionate have been 
shown to represent 95% of the SCFA  in the gut (Ley et al., 2006). Moreover, the 
phylum of Firmicutes have been shown to mainly produce butyrate while acetate and 
propionate mainly are produced from the Bacteroidetes phylum (Ley et al., 2006). 
Still the actual level of SCFA is difficult to determine due to absorption in the gut, and 
thus the SCFA in feaces is not the true level in the GI tract (den Besten et al., 2013). 
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The degree of uptake of SCFA in the GI is mainly unknown (den Besten et al., 2013). 
This study, however, is unique in the incubation manner since it hasn’t been applied 
in this context of in vitro to in vivo method before. A hypothesis that a better reflection 
of the potential production of SCFA will be shown compare to measuring the SCFA 
direct in feaces, due to unknown absorption. A conclusion of faecal SCFA could be 
made for a better estimation of production and absorption when a known rate of 
production is set.  
Bacteria 
Bacteroidetes and Firmicutes in abundance to each other have through biochemical 
and metagenomic analyses in rats suggested to be related to obesity (Turnbaugh et 
al., 2006). A significant increase in body fat percentage was shown when of a germ-
free mice was colonised with Bacteroidetes and Firmicutes “obese” microbiota, 
awakening a potential factor behind the pathophysiology of obesity. These two 
bacteria in proportion to each other with an increased level of Firmicutes compared to 
Bacteroidetes were assumed to be associated with obesity, even in humans (Ley et 
al,. 2006; Ley et al,. 2005). The increase of Firmicutes has been shown to be an 
indirect factor for extra supply of energy for the host due to production of SCFA 
(Scheppach W,. 1994). A correlation between Firmicutes and Bacteroidetes was 
observed in this study as well, when one increases the other one decrease, but due 
to relative measurements, it’s difficult to conclude from this observation. A absolute 
quantification would be better here, especially on a more detailed level of a genus or 
even species level. Prevotella is, for example, an important species within the 
Firmicutes group and a next step could be to target and quantify specifically this 
group. Further, no correlation between Bacteroidetes and BMI was found in this 
study, in accordance with previous studies (Duncan et al., 2008; Ducan et al., 2007; 
Schwiertz et al., 2010), suggesting this bacterial group not to be of centrally 
importance for obesity.  
No correlation between Bifidobacterium and BMI could not be seen in this study 
either, compare to Schwiertz and co-workers whose result showed a significant level 
of Bifidobacterium with a lower level in the obese subjects (Schwiertz et al., 2010). 
However, lifestyles-related factors haven’t been recorded which could have an 
impact on the gut microbiota and indirect bacteria’s, which makes it difficult to draw 
an absolute conclusion.  
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Summary of conclusion  
In summary, this study showed a significant lower level of the specific methanogen 
MBT and a higher level of total SCFA in the obese compared to lean group. The 
increase of the SCFA production gets absorbed and subsequently serves an energy 
source for the human host and weight gain due to this. In this study no consideration 
was taken for influencing factors for obesity such as lifestyles-related factors as the 
participant’s diet, activity, habitation or heritage. The importance of methanogens and 
bacteria could therefore be difficult to draw, but the results definitely awakening 
potential prevention targets for obesity and further investigations since some 
significant changes are seen in the induvial groups. More clinical studies are needed 
to be able to draw a more definite conclusion, where the subjects report a more 
detailed lifestyle in dieting and activity etc to further establish a consistent theory 
about the correlation between intestinal microbiota and obesity. An obesity biomarker 
or a methanogen therapeutic target is therefore not yet established, where a more 
consistent theory of the intestinal influence of the microbiota in obesity is in needed. 
However, lifestyle factors seem to be the biggest influence at the moment and where, 
for example, a vegetarian diet has shown to help in weight reduction greater than a 
normal diet which could be a helpful tool to introduce to obese people in general 
(Huang et al., 2016).  
 
Strength and limitations  
Limitation for the study was undetectable methanogens in most of the analysed 
groups, except MBT. Another limitation was the loss of 3 samples from each group 
due to inefficient PCR. This decreased the number of subjects further in each group. 
However, an increase in analytic precision was established when triplicate of each 
samples was made throughout our laboratory analysis. Regarding age and sex is 
there a potential difference in age for methanogen abundance but not for sex. A 
strength for this study is accordingly the similarity between the two groups regarding 
age and sex distribution. The number of participants in the study is a limitation where 
a bigger group of participants could have shown potentially small but clinically 
23  
 
relevant findings. Since all obese participants were patients at Uppsala university a 
slight selection bias occurred which is a further limitation for the study. 
 
Concluding remarks  
In conclusion, this study shows a new way of measuring methanogen and SCFA 
production in the GI tract. A significant correlation between MBT and BMI was seen. 
Also, a significant correlation between total SCFA and BMI and SCFA towards MBT 
was shown. However, no correlation towards bacteria’s and obesity at the genus and 
phylum levels was found. Studies with a larger study population and a bigger 
selection ratio then this study would be strengthening our findings. The model of in 
vitro and in vivo would be a recommendation for small but important detection, since 
this shows a greater potential of the growth of the microbiota and could help to 
increase the low but important changes in the composition of the microbiome.  
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